by Sayer Ji, Green Med Info:
Hepatitis C, commonly understood to be caused by a silent yet deadly virus, affects millions worldwide, with many facing grim prognoses and exorbitant costs due to the shortcomings of conventional therapies. Yet, hidden in the shadows of the pharmaceutical industry, a natural and highly effective alternative treatment exists–one that could save lives and significantly reduce healthcare costs, but remains overlooked because it’s not patentable.
TRUTH LIVES on at https://sgtreport.tv/
Understanding Hepatitis C: Prevalence and Impact
Hepatitis C is a pervasive and insidious viral infection that affects an estimated 58 million people globally.1 The primary cause is believed to be a virus, primarily transmitted through blood-to-blood contact, and which is understood to remain asymptomatic for decades, earning its reputation as a “silent killer.” When symptoms do emerge, they typically manifest as liver-related issues, ranging from cirrhosis to hepatocellular carcinoma. Each year, approximately 400,000 people die from Hepatitis C-related liver diseases, making it a significant global health burden.2
The Prognosis of Chronic Hepatitis C
Without proper treatment, chronic Hepatitis C leads to severe liver damage, cirrhosis, and liver cancer. For many, the prognosis is bleak–about 20% of those infected develop cirrhosis over 20-30 years, and a portion of these patients progress to liver cancer.3 The liver transplantation rate for Hepatitis C patients has skyrocketed in recent years, and the demand is expected to increase dramatically in the next two decades.4 For those who do not receive effective treatment, the outcome is often fatal.
Current Treatment Modalities: Interferon and Antiviral Therapies
The standard treatment for Hepatitis C involves a combination of antiviral drugs, often including interferon and ribavirin. These therapies, while effective in some cases, come with a host of challenges. The success rate of interferon therapy is notoriously low, with less than 30% of patients achieving sustained virological response (SVR), meaning the virus remains undetectable in their blood six months post-treatment.5 Additionally, these treatments are accompanied by severe side effects, including flu-like symptoms, depression, and even severe anemia, making them intolerable for many patients.6
The High Cost of Conventional Treatment
The financial burden of Hepatitis C treatment is staggering. Newer antiviral drugs, such as sofosbuvir and ledipasvir, have improved SVR rates but come with a hefty price tag. A 12-week course of these drugs can cost upwards of $84,000,7 making them inaccessible to many patients, especially in low-income countries. For those who progress to end-stage liver disease, the cost of a liver transplant can exceed $300,000, with ongoing costs for anti-rejection medications and follow-up care adding significantly to the lifetime expense.8
Dangers and Limitations of Current Therapies
The limitations of current therapies extend beyond their financial cost. The side effects associated with interferon-based therapies can be debilitating, leading many patients to discontinue treatment prematurely.9 Moreover, the effectiveness of these treatments is limited by the presence of comorbid conditions, such as HIV, which can further complicate the management of Hepatitis C.10 In many cases, even after successful treatment, patients remain at risk of liver cancer due to the residual damage caused by the virus.11
The Natural Therapy that Could Revolutionize Hepatitis C Treatment
In contrast to the conventional therapies, a promising natural treatment protocol has emerged, combining three potent antioxidants: alpha-lipoic acid, silymarin (milk thistle), and selenium. This “triple antioxidant therapy” has shown remarkable success in treating chronic Hepatitis C, with patients experiencing significant improvements in liver function and overall health.12
Alpha-lipoic acid is a powerful antioxidant that not only neutralizes free radicals but also regenerates other antioxidants, such as vitamin C and glutathione.13 Silymarin, extracted from the milk thistle plant, has been used for centuries as a liver tonic and has demonstrated hepatoprotective properties, particularly in combating oxidative stress and inflammation.14 Selenium, an essential trace mineral, supports the body’s antioxidant defenses and plays a crucial role in immune function.15
Clinical Evidence: Success Stories of Triple Antioxidant Therapy
A landmark study conducted by Dr. Burton Berkson presented compelling evidence supporting the efficacy of this therapy. In his study, three patients with advanced Hepatitis C–who had been deemed candidates for liver transplantation–were treated with the triple antioxidant regimen.16 Remarkably, all three patients showed significant improvement in liver enzyme levels, reduced viral loads, and, most importantly, avoided the need for liver transplants.17 These patients not only survived but returned to their daily lives, free from the debilitating symptoms of chronic Hepatitis C.
Cost-Effectiveness: A Fraction of the Price
One of the most compelling aspects of this therapy is its cost-effectiveness. The annual cost of the triple antioxidant therapy is less than $2,000–a fraction of the cost of conventional antiviral treatments or liver transplantation.18 This makes it an attractive option for healthcare systems, particularly in resource-limited settings, where the financial burden of Hepatitis C is often unsustainable.
The Role of Patents in Shaping Treatment Options
Despite the promising results, the triple antioxidant therapy has not gained widespread acceptance. One of the primary reasons is that the components of this therapy–alpha-lipoic acid, silymarin, and selenium–are natural substances that cannot be patented.19 In the pharmaceutical industry, the lack of patentability often translates to a lack of financial incentive for research and development. Without the potential for lucrative patents, pharmaceutical companies are less likely to invest in large-scale clinical trials or marketing efforts for these therapies.20
